dc.creator | Ristanović, Elizabeta | |
dc.creator | Kokoskov, Nenad S. | |
dc.creator | Crozier, Ian | |
dc.creator | Kuhn, Jens H. | |
dc.creator | Gligić, Ana | |
dc.date.accessioned | 2021-02-18T10:54:09Z | |
dc.date.available | 2021-02-18T10:54:09Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1092-2172 | |
dc.identifier.uri | http://intor.torlakinstitut.com/handle/123456789/570 | |
dc.description.abstract | In 1967, several workers involved in poliomyelitis vaccine development and production fell ill at three different locations in Europe with a severe and often lethal novel disease associated with grivets (Chlorocebus aethiops) imported from Uganda. This disease was named Marburg virus disease (MVD) after the West German town of Marburg an der Lahn, where most human infections and deaths had been recorded. Consequently, the Marburg episode received the most scientific and media attention. Cases that occurred in Frankfurt am Main, West Germany, were also described in commonly accessible scientific literature, although they were less frequently cited than those pertaining to the Marburg infections. However, two infections occurring in a third location, in Belgrade, Yugoslavia, have seemingly been all but forgotten. Due in part to their absence in commonly used databases and in part to the fact that they were written in languages other than English, the important articles describing this part of the outbreak are very rarely cited. Here, we summarize this literature and correct published inaccuracies to remind a younger generation of scientists focusing on Marburg virus and its closest filoviral relatives of this important historical context. Importantly, and unfortunately, the three episodes of infection of 1967 still represent the best in-depth clinical look at MVD in general and in the context of "modern" medicine (fully resourced versus less-resourced capacity) in particular. Hence, each individual case of these episodes holds crucial information for health care providers who may be confronted with MVD today. | en |
dc.publisher | Amer Soc Microbiology, Washington | |
dc.relation | Laulima Government Solutions, LLC | |
dc.relation | U.S. National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health | |
dc.relation | NIAIDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH | |
dc.relation | Laulima Government Solutions, LLC [HHSN272201800013C] | |
dc.relation | federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH) [HHSN261 | |
dc.relation | Clinical Monitoring Research Program Directorate, Frederick National Lab for Cancer Research - NCI | |
dc.rights | restrictedAccess | |
dc.source | Microbiology and Molecular Biology Reviews | |
dc.subject | Belgrade | en |
dc.subject | Filoviridae | en |
dc.subject | filovirus | en |
dc.subject | Marburg hemorrhagic fever | en |
dc.subject | marburgvirus | en |
dc.subject | Marburg virus | en |
dc.subject | Marburg virus disease | en |
dc.subject | MHF | en |
dc.subject | MVD | en |
dc.subject | Torlak | en |
dc.subject | VHF | en |
dc.subject | viral hemorrhagic fever | en |
dc.title | A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967 | en |
dc.type | article | |
dc.rights.license | ARR | |
dc.citation.issue | 2 | |
dc.citation.other | 84(2) | |
dc.citation.rank | aM21 | |
dc.citation.volume | 84 | |
dc.identifier.doi | 10.1128/MMBR.00095-19 | |
dc.identifier.pmid | 32404328 | |
dc.identifier.scopus | 2-s2.0-85084626647 | |
dc.identifier.wos | 000540853300010 | |
dc.type.version | publishedVersion | |